News

News

THE PHASE CLINICAL TRIAL OF LT-FLU NASAL FLU VACCINE HAS BEEN PUBLISHED ON THE JOURNAL VACCINE.

Receives TFDA approval to conduct phase II clinical trial of AD17002 for the treatment of moderate-to-severe eosinophilic asthma.

2025-08-11

公開資訊觀測站精華版本資料由　(興櫃公司) 6709 昱厚生技　公司提供序號 1 發言日期 114/08/11 發言時間 16:03:38 發言人徐悠深發言人職稱 ...

【環球生技月刊】昱厚氣喘新藥獲TFDA核准執行臨床二期試驗

【環球生技月刊】昱厚氣喘新藥獲TFDA核准執行臨床二期試驗

2025-08-11

Submits IND application to TFDA for phase II clinical trial of AD17002 in the treatment of moderate-to-severe eosinophilic asthma.

2025-06-16

公開資訊觀測站精華版本資料由　(興櫃公司) 6709 昱厚生技　公司提供序號 2 發言日期 114/06/16 發言時間 15:30:42 發言人徐悠深發言人職稱 ...

【環球生技月刊】昱厚鼻噴氣喘新藥向TFDA正式遞交臨床二期試驗申請

2025-06-16

【財訊快報】昱厚生技AD17002鼻噴新藥，預計10家醫療中心啟動正式二期臨床

2025-03-14

【鉅亨網】昱厚AD17002鼻噴新藥正式啟動臨床二期

2025-03-14

【MoneyDJ】昱厚嚴重氣喘鼻噴新藥探索性二期臨床數據達標

2025-03-06

Submits interim analysis report of AD17002 nasal spray for asthma treatment to TFDA and announces early termination of the clinical trial.

2025-03-05

公開資訊觀測站精華版本資料由　(興櫃公司) 6709 昱厚生技　公司提供序號 2 發言日期 114/03/05 發言時間 18:01:55 發言人徐悠深發言人職稱 ...

【工商時報】昱厚嚴重氣喘鼻噴新藥探索性二期臨床數據達標

2025-03-05

【環球生技月刊】昱厚鼻噴新冠免疫治療藥臨床二a期試驗加速清病毒、縮短病程登國際期刊

【環球生技月刊】昱厚鼻噴新冠免疫治療藥臨床二a期試驗加速清病毒、縮短病程登國際期刊

2024-12-11

【經濟日報】昱厚鼻噴新冠免疫治療藥臨床二a期成果登國際期刊

2024-12-11

The results of the Phase 2a clinical trial of the nasal spray COVID-19 immunotherapy drug AD17002 were published in the journal Human Vaccines & Immunotherapeutics. The study demonstrates that AD17002 shows good safety and tolerability in patients wit

2024-12-11

This site uses cookies to collect the necessary user browsing behavior so that we can provide you with a better browsing experience. Browse this site, which means you agree with "online privacy declaration."